SRL
SLNO

Scientech Research LLC’s Soleno Therapeutics SLNO Stock Holding History

Scientech Research LLC’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,126
Closed -$376K – 707
2025
Q4 		$376K Buy
+8,126
New +$446K 0.24% 151
2025
Q2 		– Sell
-11,620
Closed -$830K – 826
2025
Q1 		$830K Buy
11,620
+6,351
+121% +$309K 0.22% 194
2024
Q4 		$237K Sell
5,269
-6,959
-57% -$361K 0.07% 465
2024
Q3 		$617K Buy
+12,228
New +$585K 0.12% 327

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Scientech Research LLC's SLNO Position: Q1 2026 in Review

Scientech Research LLC sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 8,126 shares — an estimated $376K sold.

Scientech Research LLC first reported a position in SLNO in Q3 2024 and held it in 4 quarters. The position peaked at $830K in Q1 2025. 226 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Scientech Research LLC reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 8,126 Soleno Therapeutics shares in Q1 2026, an estimated $376K.
  • Scientech Research LLC first reported a position in Soleno Therapeutics in Q3 2024 and held it in 4 quarters.
  • Scientech Research LLC's Soleno Therapeutics position peaked at $830K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.